BRAF mutations occur with a low prevalence of only 2–5% in Caucasian lung cancers, and V600 mutations (amino acid substitution for valine at position 600) accounted for ~50%, with the rest of cases harbor non-V600 mutations (3–5). Here, BRAF is linked to lung carcinoma.